Acurx Pharmaceuticals, Inc. Announces $4.225M Registered Direct Offering
Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a clinical-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today